RecruitingNot ApplicableNCT07238699

An Evaluation of the Safety and Tolerability of Ocular Lubricants


Sponsor

Alcon Research

Enrollment

148 participants

Start Date

Mar 4, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to evaluate the safety and tolerability of two new artificial tear formulations in subjects with moderate dry eye disease.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Subject must be willing and able to understand and sign an ethics committee approved informed consent form.
  • Subject must be willing and able to attend all study visits as required by the protocol.
  • Subject must exhibit symptoms of dry eye at the Screening Visit.
  • Subject must currently use artificial tears.

Exclusion Criteria4

  • Has any known active ocular disease and/or infection.
  • Has any known infection or inflammation that requires treatment or has a systemic condition that, in the opinion of the investigator, may affect a study outcome variable.
  • Any ocular injury to either eye in the 12 weeks prior to screening.
  • Current wearer of contact lenses or has a history of contact lens wear within the previous 1 month.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFID123440 test formulation

Investigational product

OTHERFID123437 test formulation

Investigational product

OTHERFID123440 test formulation

Investigational product


Locations(4)

School of Optometry and Vision

Sydney, New South Wales, Australia

Ophthalmic Trials Australia

Teneriffe, Queensland, Australia

The University of Melbourne, Department of Optometry and Vision Science

Carlton, Victoria, Australia

Deakin Collaborative Eye Care Clinic, Deakin University

Waurn Ponds, Victoria, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07238699


Related Trials